Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
Legal · COJuly 2, 2026

Federal Judge Blocks Colorado Drug Affordability Board Price Cap on Amgen's Enbrel

A federal judge has blocked Colorado's Drug Affordability Board from implementing a price cap on Amgen's Enbrel, a blockbuster rheumatoid arthritis medication. The ruling prevents the state board from enforcing its pricing limit on the drug. The decision affects Colorado's ability to use its drug affordability review process to control costs for high-priced medications. This represents a significant setback for state efforts to directly regulate pharmaceutical pricing through affordability boards, with implications for how states can address drug costs in Medicaid programs.

Why it mattersThe ruling limits states' ability to impose price caps on high-cost medications, potentially constraining Medicaid managed care organizations' options for controlling pharmacy costs and challenging state-level drug affordability initiatives that MCOs rely on to manage specialty drug spending.

Pharmacy · Managed Care

Read the full article at statnews.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.